E-LIB Suche - Ergebnisse für: Sibolt, O.

1

P815: Automatic detection of change in emotional expression..:

Kreegipuu, K. ; Kuldkepp, N. ; Sibolt, O....
Clinical Neurophysiology. 125 (2014) - p. S260-S261 , 2014

Link: https://doi.org/10.1016/..

2

PO-0909 Development and experimental validation of a user c..:

Sibolt, P. ; Andersen, C.E. ; Behrens, C.F...
Radiotherapy and Oncology. 133 (2019) - p. S483-S484 , 2019

Link: https://doi.org/10.1016/..

3

Automated four-dimensional Monte Carlo workflow using log f..:

Sibolt, P ; Cronholm, R O ; Heath, E..
Journal of Physics: Conference Series. 847 (2017) - p. 012030 , 2017

Link: https://doi.org/10.1088/..

4

Abstract ID: 78 Verification of time-resolved Monte Carlo s..:

Sibolt, Patrik ; Andersen, Claus E. ; Behrens, Claus F...
Physica Medica. 42 (2017) - p. 15-16 , 2017

Link: https://doi.org/10.1016/..

5

Ultra-acute diagnostics for stroke: Large-scale implementat..:

Mattila, O. S. ; Harve, H. ; Pihlasviita, S....
Acta Neurologica Scandinavica. 136 (2016) 1 - p. 17-23 , 2016

Link: https://doi.org/10.1111/..

6

Measurements of the relative backscatter contribution to th..:

Sibolt, Patrik ; Cronholm, Rickard O. ; Beierholm, Anders R..
Radiation Measurements. 72 (2015) - p. 75-80 , 2015

Link: https://doi.org/10.1016/..

7

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..

8

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..

9

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..

10

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..

11

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..

12

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..

13

Safety and efficacy of tenecteplase in patients with wake-u..:

Roaldsen, MB ; Eltoft, A ; Wilsgaard, T...
https://discovery.ucl.ac.uk/id/eprint/10167081/2/Werring_Revised_manuscript_THELANCETNEUROLOGY-D-22-008%20CLEAN.pdf. , 2023

Link: https://discovery.ucl.ac..

14

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..

15

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..